Skip to main content

Advertisement

Table 7 Comparison according to treatment modality (n = 63)

From: Biological characteristics and treatment outcomes of metastatic or recurrent neuroendocrine tumors: tumor grade and metastatic site are important for treatment strategy

   Local
treatment
Systemic
treatment
Both
treatments
P-value
Grade 1
2-3
Large
Small
14 (73.7%)
3 (15.8%)
1 (5.3%)
1 (5.3%)
7 (38.9%)
8 (44.4%)
3 (16.7%)
0 (O.0%)
13 (50.0%)
3 (11.5%)
5 (19.2%)
5 (19.2%)
.037
Metastatic site Extrahepatic metastasis
Liver metastasis only
7 (33.3%)
14 (66.7%)
17 (77.3%)
5 (22.7%)
11 (52.4%)
10 (47.6%)
.015